We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest News

News

Aida Pharmaceuticals Announces new Antibiotic Drug under Development

Company’s recently-acquired research institute is developing a new wide-spectrum antibiotic for the treatment of various inflammations.
News

Abraxis BioScience Announces Approval to Market ABRAXANE for Metastatic Breast Cancer in Korea

Korean FDA grants marketing approval for Abraxis’ ABRAXANE® for the treatment of breast cancer after failure of standard chemotherapy for metastatic disease.
News

GENEART Awarded European Patent for Tested HIV Vaccines

The patent protects the use of certain custom-designed HIV gene sequences for the development of therapeutics or vaccines in some European countries.
News

Researchers Learn How Signaling Molecule Orchestrates Breast Cancer's Spread

Researchers at Memorial Sloan-Kettering Cancer Center have uncovered how breast tumors use a particular type of molecule to promote metastasis.
News

PerkinElmer Partners with Cerep for Custom Drug Discovery Solutions

Supply and co-marketing agreement will provide biotechnology and pharmaceutical customers with a total solution for drug candidate detection and validation.
News

Open Biosystems' Open Access RNAi Program Adopted by University of Copenhagen and University of Queensland

Both institutions purchased access to Open Biosystems' lentiviral shRNAmir human and mouse libraries.
News

Genetic Variations Raise Lung Cancer Risk for Smokers and Ex-Smokers

Two common inherited genetic variations are associated with increased risk of lung cancer for smokers and former smokers, according to research.
News

BioTrove Combines Forces with OSI Pharmaceuticals to Enable Lead Discovery

Strategic alliance combines OSI’s lead discovery platform and BioTrove’s RapidFire™ screening technology to accelerate client lead discovery.
News

Asuragen Launches Mirna Therapeutics to Develop and Commercialize microRNA Oncology Therapeutics

Mirna is developing miRNA replacement therapies, using miRNAs as drugs to correct the down-regulation of miRNAs that occurs in many human cancers.
News

Roche Applied Science Selects the Technology of NuGEN WT-Ovation™ as RNA Amplification Product for LightCycler® System

Roche signs agreement to market and sell an RNA amplification product based on the technology of NuGEN’s proprietary WT-Ovation™.
Advertisement